Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Delirium

3,4-methylenedioxyamphetamine has been researched along with Delirium in 3 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ronan, GP1
Ronan, N1
McGettigan, S1
Browne, G1
Kaskey, GB1
Resnick, PJ1

Other Studies

3 other studies available for 3,4-methylenedioxyamphetamine and Delirium

ArticleYear
Serotonin syndrome unmasking thyrotoxicosis.
    BMJ case reports, 2019, Mar-07, Volume: 12, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Aftercare; Anti-Arrhythmia Agents; Antithyroid Agents; Carbima

2019
Possible interaction between an MAOI and "ecstasy".
    The American journal of psychiatry, 1992, Volume: 149, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Coma; Delirium; Designer Drugs; Drug Interactions; Female

1992
Child murder by parents: a psychiatric review of filicide.
    The American journal of psychiatry, 1969, Volume: 126, Issue:3

    Topics: Accidents; Adolescent; Adult; Child; Child Abuse; Child, Preschool; Delirium; Epilepsy; Euthanasia;

1969